|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Amlodipine#Nonclinical Toxicology]] |
| {{Amlodipine}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| == Nonclinical Toxicology==
| |
| | |
| === Carcinogenesis, Mutagenesis, Impairment of Fertility===
| |
| | |
| Rats and mice treated with amlodipine maleate in the diet for up to two years, at concentrations calculated to provide daily dosage levels of 0.5, 1.25, and 2.5 amlodipine mg/kg/day, showed no evidence of a carcinogenic effect of the drug. For the mouse, the highest dose was, on a mg/m2 basis, similar to the maximum recommended human dose of 10 mg amlodipine/day.<sup>10</sup> For the rat, the highest dose was, on a mg/m2 basis, about twice the maximum recommended human dose.<sup>11</sup>
| |
| | |
| Mutagenicity studies conducted with amlodipine maleate revealed no drug related effects at either the gene or chromosome level.
| |
| | |
| There was no effect on the fertility of rats treated orally with amlodipine maleate (males for 64 days and females for 14 days prior to mating) at doses up to 10 mg amlodipine/kg/day (8 times the maximum recommended human dose<sup>12</sup> of 10 mg/day on a mg/m2 basis).
| |
| | |
| <sup>10</sup>Based on patient weight of 50 kg
| |
| | |
| <sup>11</sup>Based on patient weight of 50 kg
| |
| | |
| <sup>12</sup>Based on patient weight of 50 kg<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NORVASC (AMLODIPINE BESYLATE) TABLET [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44e5ad27-e062-461a-bdf4-192d852fbc49#nlm42230-3 | publisher = | date = | accessdate = 6 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
|
| |
|
| [[Category:Cardiovascular Drugs]] | | [[Category:Cardiovascular Drugs]] |
| [[Category:Drugs]] | | [[Category:Drugs]] |